Study evaluating the clinical impact of HDM201 + Pazopanib in patients with P53 wild-type advanced/ metastatic soft tissue sarcomas.

2024-510706-86-00 Protocol ET20-297 Phase I and Phase II (Integrated) - Other Ongoing, recruiting

Start 16 May 2022 · Status Ongoing, recruiting · 1 EU/EEA countries · 5 sites · Protocol ET20-297

Overview

Sponsor-declared trial summary

Phase Phase I and Phase II (Integrated) - Other
Status Ongoing, recruiting
Participants planned 58
Countries 1
Sites 5

Advanced/ metastatic soft tissue sarcomas

Key facts

Sponsor
Centre Leon Berard
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Neoplasms [C04]
Trial duration
16 May 2022 → ongoing
Decision date (initial)
2024-11-05
Transition trial
Yes
Low-intervention
No
Rare-disease indication
Yes
Vulnerable population
No

External identifiers

EU CT number
2024-510706-86-00
EudraCT number
2020-005494-26
ClinicalTrials.gov
NCT05180695

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Advanced/ metastatic soft tissue sarcomas

VersionLevelCodeTermSystem organ class
20.0 PT 10075333 Soft tissue sarcoma 100000004864

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Centre Leon Berard

Sponsor organisation
Centre Leon Berard
Address
28 Rue Laennec
City
Lyon
Postcode
69008
Country
France

Scientific contact point

Organisation
Centre Leon Berard
Contact name
Pr Jean Yves BLAY

Public contact point

Organisation
Centre Leon Berard
Contact name
Clinical project manager

Locations

1 EU/EEA country · 5 investigational sites

By country

CountryMS statusPlanned subjectsSites
France Ongoing, recruiting 58 5
Rest of world 0

Investigational sites

France

5 sites · Ongoing, recruiting
Oncopole Claudius Regaud
Medical oncology, 1 Avenue Irene Joliot Curie, 31059, Toulouse Cedex 9
Institut Gustave Roussy
Medical oncology, 39 Rue Camille Desmoulins, 94805, Villejuif Cedex
Institut Bergonie
Medical oncology, 180 R De Saint Genes, 229 Cours De L Argonne, Bordeaux
Institut Paoli Calmettes
Medical oncology, 232 Boulevard De Sainte Marguerite, Bp 156, Marseille
Centre Leon Berard
Medical oncology, 28 Rue Laennec, 69008, Lyon

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
France 2022-05-16 2022-05-16

Application history

3 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-09-26 France Acceptable
2024-11-05
2024-11-05
2 NON SUBSTANTIAL MODIFICATION NSM-1 2025-06-17 France Acceptable
2024-11-05
2025-06-17
3 SUBSTANTIAL MODIFICATION SM-1 2025-06-20 France Acceptable
2025-07-17
2025-07-24